Sinclair Research has announced the appointment of Mark Lane as director of business development. In this role, Lane will have responsibility for the San Francisco to Seattle corridor. He will be responsible for driving the growth of Sinclair’s IND enabling toxicology and efficacy models and fostering positive relationships with new and current customers.
Lane joins Sinclair with more than 25 years of experience in the contract research organization industry. He has extensive experience in DMPK, safety pharmacology, experimental therapeutics and molecular imaging.
“Sinclair is fortunate to recruit such an outstanding industry veteran. Mark’s industry knowledge and welcoming style are a great fit for our company and our market,” said Mark Crane.